Hospital Universitari Vall d'Hebron, Vall d'Hebron Institute of Oncology

Barcelona 08035

0 studies enrolling now · 1 studies all time

What they study most

Follicular Lymphoma (FL), Marginal Zone Lymphoma, Non Hodgkin Lymphoma

Studies at this site

• Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL) — Stopped early